

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | negative regulation of complement activation (GO:0045916) | 7.68436071 |
| 2 | positive regulation of endothelial cell differentiation (GO:0045603) | 7.09029435 |
| 3 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan (GO:0019800) | 6.92637866 |
| 4 | negative regulation of protein activation cascade (GO:2000258) | 6.84635476 |
| 5 | negative regulation of humoral immune response (GO:0002921) | 6.47853150 |
| 6 | lung lobe morphogenesis (GO:0060463) | 6.43989623 |
| 7 | regulation of endothelial cell differentiation (GO:0045601) | 6.42461651 |
| 8 | endothelial tube morphogenesis (GO:0061154) | 6.10005076 |
| 9 | morphogenesis of an endothelium (GO:0003159) | 6.10005076 |
| 10 | response to xenobiotic stimulus (GO:0009410) | 5.86331546 |
| 11 | dichotomous subdivision of an epithelial terminal unit (GO:0060600) | 5.81560344 |
| 12 | pattern specification involved in kidney development (GO:0061004) | 5.42451970 |
| 13 | regulation of vasculogenesis (GO:2001212) | 5.09497393 |
| 14 | positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:00360 | 4.85704744 |
| 15 | respiratory tube development (GO:0030323) | 4.82333524 |
| 16 | peptide catabolic process (GO:0043171) | 4.78743489 |
| 17 | blood vessel maturation (GO:0001955) | 4.73286058 |
| 18 | lung vasculature development (GO:0060426) | 4.63461162 |
| 19 | epithelial tube branching involved in lung morphogenesis (GO:0060441) | 4.54233270 |
| 20 | phosphate ion transmembrane transport (GO:0035435) | 4.46606303 |
| 21 | mesodermal cell differentiation (GO:0048333) | 4.38127306 |
| 22 | lymphangiogenesis (GO:0001946) | 4.21989674 |
| 23 | regulation of transcription from RNA polymerase II promoter in response to oxidative stress (GO:0043 | 4.21655911 |
| 24 | establishment of apical/basal cell polarity (GO:0035089) | 4.21039502 |
| 25 | sodium-independent organic anion transport (GO:0043252) | 4.20275313 |
| 26 | regulation of complement activation (GO:0030449) | 4.14982784 |
| 27 | endocardial cushion development (GO:0003197) | 4.05147644 |
| 28 | trivalent inorganic anion homeostasis (GO:0072506) | 4.04036016 |
| 29 | phosphate ion homeostasis (GO:0055062) | 4.04036016 |
| 30 | adhesion of symbiont to host cell (GO:0044650) | 4.00863986 |
| 31 | virion attachment to host cell (GO:0019062) | 4.00863986 |
| 32 | cellular response to thyroid hormone stimulus (GO:0097067) | 3.95812811 |
| 33 | cellular hyperosmotic response (GO:0071474) | 3.91245490 |
| 34 | regulation of phospholipid biosynthetic process (GO:0071071) | 3.91219362 |
| 35 | artery development (GO:0060840) | 3.90119415 |
| 36 | epithelial cell differentiation involved in prostate gland development (GO:0060742) | 3.86578820 |
| 37 | regulation of protein activation cascade (GO:2000257) | 3.82128219 |
| 38 | hemidesmosome assembly (GO:0031581) | 3.77751441 |
| 39 | positive regulation of vasculogenesis (GO:2001214) | 3.75796215 |
| 40 | hyperosmotic salinity response (GO:0042538) | 3.75231717 |
| 41 | cellular anion homeostasis (GO:0030002) | 3.72401726 |
| 42 | lung alveolus development (GO:0048286) | 3.70655489 |
| 43 | sodium ion homeostasis (GO:0055078) | 3.70388263 |
| 44 | embryonic foregut morphogenesis (GO:0048617) | 3.64096656 |
| 45 | phosphate ion transport (GO:0006817) | 3.60420999 |
| 46 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 3.59046200 |
| 47 | establishment or maintenance of monopolar cell polarity (GO:0061339) | 3.56637109 |
| 48 | establishment of monopolar cell polarity (GO:0061162) | 3.56637109 |
| 49 | cellular response to antibiotic (GO:0071236) | 3.54825861 |
| 50 | negative regulation of pathway-restricted SMAD protein phosphorylation (GO:0060394) | 3.54771587 |
| 51 | renal absorption (GO:0070293) | 3.50013739 |
| 52 | regulation of glomerular filtration (GO:0003093) | 3.47680693 |
| 53 | glomerular epithelial cell development (GO:0072310) | 3.47427508 |
| 54 | positive regulation of digestive system process (GO:0060456) | 3.46282290 |
| 55 | cell adhesion mediated by integrin (GO:0033627) | 3.44055550 |
| 56 | * respiratory gaseous exchange (GO:0007585) | 3.42613630 |
| 57 | regulation of integrin-mediated signaling pathway (GO:2001044) | 3.39488997 |
| 58 | lung secretory cell differentiation (GO:0061140) | 3.36027839 |
| 59 | complement activation (GO:0006956) | 3.34976964 |
| 60 | protein localization to endosome (GO:0036010) | 3.33027525 |
| 61 | glomerular filtration (GO:0003094) | 3.32547232 |
| 62 | adhesion of symbiont to host (GO:0044406) | 3.32367485 |
| 63 | iron ion import (GO:0097286) | 3.31963418 |
| 64 | endocrine hormone secretion (GO:0060986) | 3.31628481 |
| 65 | regulation of cardioblast differentiation (GO:0051890) | 3.31423334 |
| 66 | wound healing, spreading of epidermal cells (GO:0035313) | 3.30518960 |
| 67 | vascular endothelial growth factor signaling pathway (GO:0038084) | 3.29998888 |
| 68 | membrane protein proteolysis (GO:0033619) | 3.26823479 |
| 69 | polyol transport (GO:0015791) | 3.26420071 |
| 70 | complement activation, classical pathway (GO:0006958) | 3.24877026 |
| 71 | ethanol oxidation (GO:0006069) | 3.23026896 |
| 72 | macrophage chemotaxis (GO:0048246) | 3.22961123 |
| 73 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 3.22928750 |
| 74 | extracellular matrix assembly (GO:0085029) | 3.18635820 |
| 75 | icosanoid transport (GO:0071715) | 3.16260786 |
| 76 | fatty acid derivative transport (GO:1901571) | 3.16260786 |
| 77 | lymph vessel development (GO:0001945) | 3.12576751 |
| 78 | glomerular visceral epithelial cell development (GO:0072015) | 3.12495808 |
| 79 | toxin metabolic process (GO:0009404) | 3.10895787 |
| 80 | endothelial cell differentiation (GO:0045446) | 3.10422886 |
| 81 | branching involved in salivary gland morphogenesis (GO:0060445) | 3.07786368 |
| 82 | polarized epithelial cell differentiation (GO:0030859) | 3.07269753 |
| 83 | phosphatidylglycerol acyl-chain remodeling (GO:0036148) | 3.07233296 |
| 84 | negative regulation of response to reactive oxygen species (GO:1901032) | 3.05837753 |
| 85 | regulation of interleukin-13 production (GO:0032656) | 3.02243704 |
| 86 | negative regulation of interleukin-2 production (GO:0032703) | 3.00651057 |
| 87 | hormone catabolic process (GO:0042447) | 2.99609017 |
| 88 | regulation of branching involved in prostate gland morphogenesis (GO:0060687) | 2.98421775 |
| 89 | hydrogen peroxide biosynthetic process (GO:0050665) | 2.97658699 |
| 90 | renal filtration (GO:0097205) | 2.97538969 |
| 91 | endothelial cell chemotaxis (GO:0035767) | 2.97489276 |
| 92 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules (GO:0016338) | 2.97209945 |
| 93 | branch elongation of an epithelium (GO:0060602) | 2.96809629 |
| 94 | tight junction assembly (GO:0070830) | 2.94952527 |
| 95 | negative regulation of immunoglobulin mediated immune response (GO:0002890) | 2.93149343 |
| 96 | negative regulation of B cell mediated immunity (GO:0002713) | 2.93149343 |
| 97 | norepinephrine metabolic process (GO:0042415) | 2.92390113 |
| 98 | response to thyroid hormone (GO:0097066) | 2.90953378 |
| 99 | blood vessel remodeling (GO:0001974) | 2.90918613 |
| 100 | regulation of hippo signaling (GO:0035330) | 2.90497301 |
| 101 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 2.89583687 |
| 102 | sphingosine metabolic process (GO:0006670) | 2.88431774 |
| 103 | positive regulation of chemokine secretion (GO:0090197) | 2.87951775 |
| 104 | apoptotic cell clearance (GO:0043277) | 2.87418876 |
| 105 | negative regulation of cytokine biosynthetic process (GO:0042036) | 2.87320548 |
| 106 | positive regulation of p38MAPK cascade (GO:1900745) | 2.87194174 |
| 107 | axis elongation (GO:0003401) | 2.86100162 |
| 108 | neuron remodeling (GO:0016322) | 2.85846832 |
| 109 | membrane raft organization (GO:0031579) | 2.84821060 |
| 110 | negative regulation of stress fiber assembly (GO:0051497) | 2.84387243 |
| 111 | establishment of epithelial cell polarity (GO:0090162) | 2.83687244 |
| 112 | protein activation cascade (GO:0072376) | 2.83663624 |
| 113 | * cellular response to nitric oxide (GO:0071732) | 2.83266407 |
| 114 | positive regulation of phagocytosis (GO:0050766) | 2.82123059 |
| 115 | T cell mediated immunity (GO:0002456) | 2.81725628 |
| 116 | cellular response to vascular endothelial growth factor stimulus (GO:0035924) | 2.80337811 |
| 117 | renal system process involved in regulation of blood volume (GO:0001977) | 2.79381616 |
| 118 | regulation of smooth muscle cell differentiation (GO:0051150) | 2.75451373 |
| 119 | midgut development (GO:0007494) | 2.75381766 |
| 120 | mesenchymal cell proliferation (GO:0010463) | 2.75266922 |
| 121 | retina vasculature morphogenesis in camera-type eye (GO:0061299) | 2.74110351 |
| 122 | establishment of endothelial barrier (GO:0061028) | 2.73685780 |
| 123 | cell migration involved in sprouting angiogenesis (GO:0002042) | 2.69355520 |
| 124 | complement activation, alternative pathway (GO:0006957) | 2.68231399 |
| 125 | positive regulation of pathway-restricted SMAD protein phosphorylation (GO:0010862) | 2.68162799 |
| 126 | negative regulation of alcohol biosynthetic process (GO:1902931) | 2.66754600 |
| 127 | negative regulation of endothelial cell proliferation (GO:0001937) | 2.66569826 |
| 128 | lung-associated mesenchyme development (GO:0060484) | 2.66109008 |
| 129 | lung morphogenesis (GO:0060425) | 2.65181545 |
| 130 | atrioventricular valve morphogenesis (GO:0003181) | 2.64178532 |
| 131 | negative regulation of hydrogen peroxide-induced cell death (GO:1903206) | 2.63258356 |
| 132 | renal system development (GO:0072001) | 2.62100177 |
| 133 | reactive oxygen species biosynthetic process (GO:1903409) | 2.61535739 |
| 134 | regulation of pathway-restricted SMAD protein phosphorylation (GO:0060393) | 2.61424581 |
| 135 | * cellular response to reactive nitrogen species (GO:1902170) | 2.61157329 |
| 136 | negative regulation of actin filament bundle assembly (GO:0032232) | 2.59934485 |
| 137 | coronary vasculature morphogenesis (GO:0060977) | 2.59251968 |
| 138 | toxin transport (GO:1901998) | 2.59037245 |
| 139 | Leydig cell differentiation (GO:0033327) | 2.58624775 |
| 140 | negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class | 2.57919672 |
| 141 | ethanol metabolic process (GO:0006067) | 2.56697474 |
| 142 | outflow tract septum morphogenesis (GO:0003148) | 2.56201125 |
| 143 | induction of positive chemotaxis (GO:0050930) | 2.56142922 |
| 144 | negative regulation of cell fate specification (GO:0009996) | 2.55415558 |
| 145 | multicellular organismal water homeostasis (GO:0050891) | 2.55346914 |
| 146 | one-carbon compound transport (GO:0019755) | 2.54664758 |
| 147 | regulation of humoral immune response (GO:0002920) | 2.53569794 |
| 148 | interleukin-6-mediated signaling pathway (GO:0070102) | 2.50632604 |
| 149 | import into cell (GO:0098657) | 2.47399583 |
| 150 | positive regulation of receptor recycling (GO:0001921) | 2.45485824 |
| 151 | arachidonic acid secretion (GO:0050482) | 2.44243970 |
| 152 | icosanoid secretion (GO:0032309) | 2.44243970 |
| 153 | prostanoid biosynthetic process (GO:0046457) | 2.42957347 |
| 154 | prostaglandin biosynthetic process (GO:0001516) | 2.42957347 |
| 155 | regulation of macrophage chemotaxis (GO:0010758) | 2.39818565 |
| 156 | regulation of chemokine secretion (GO:0090196) | 2.39227320 |
| 157 | cell volume homeostasis (GO:0006884) | 2.38401517 |
| 158 | positive regulation of type 2 immune response (GO:0002830) | 2.32442290 |
| 159 | transcytosis (GO:0045056) | 2.30045044 |
| 160 | neurological system process involved in regulation of systemic arterial blood pressure (GO:0001976) | 2.29953506 |
| 161 | regulation of p38MAPK cascade (GO:1900744) | 2.28997182 |
| 162 | positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S tr | 2.27202578 |
| 163 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.26639177 |
| 164 | surfactant homeostasis (GO:0043129) | 18.5806092 |
| 165 | chemical homeostasis within a tissue (GO:0048875) | 14.8933857 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | GATA1_22025678_ChIP-Seq_K562_Human | 6.62269494 |
| 2 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 3.96011146 |
| 3 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 3.61122056 |
| 4 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.35233865 |
| 5 | CLOCK_20551151_ChIP-Seq_293T_Human | 3.21279618 |
| 6 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 3.16961182 |
| 7 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 3.14138170 |
| 8 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 3.13346985 |
| 9 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 3.07263826 |
| 10 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.73399636 |
| 11 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.65742779 |
| 12 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 2.65274372 |
| 13 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 2.63201327 |
| 14 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 2.61997587 |
| 15 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 2.56973114 |
| 16 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 2.47071524 |
| 17 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 2.38073751 |
| 18 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.33954057 |
| 19 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 2.29234606 |
| 20 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 2.21729782 |
| 21 | SOX2_20726797_ChIP-Seq_SW620_Human | 2.18801356 |
| 22 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.06697545 |
| 23 | AHR_22903824_ChIP-Seq_MCF-7_Human | 2.05373848 |
| 24 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.98889510 |
| 25 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.93292171 |
| 26 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.91274078 |
| 27 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.90641455 |
| 28 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.88003929 |
| 29 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.82277881 |
| 30 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.80988226 |
| 31 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.71325192 |
| 32 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.70008914 |
| 33 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.68706146 |
| 34 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.67966494 |
| 35 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.62789965 |
| 36 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.61884138 |
| 37 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.61313922 |
| 38 | CJUN_26792858_Chip-Seq_BT549_Human | 1.58329261 |
| 39 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.56907111 |
| 40 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.56375080 |
| 41 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.56375080 |
| 42 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.56227915 |
| 43 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.55502143 |
| 44 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.55363425 |
| 45 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.53587733 |
| 46 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.52237810 |
| 47 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.50470896 |
| 48 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.48663871 |
| 49 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.46955745 |
| 50 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.46309255 |
| 51 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.46309255 |
| 52 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.45608783 |
| 53 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.44215499 |
| 54 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.43403692 |
| 55 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.42031199 |
| 56 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.40881573 |
| 57 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.40740011 |
| 58 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.36655290 |
| 59 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 1.35367026 |
| 60 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.34262689 |
| 61 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.33612668 |
| 62 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.33199306 |
| 63 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.32174430 |
| 64 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.29046567 |
| 65 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.28897345 |
| 66 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.27223871 |
| 67 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.26317902 |
| 68 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.25036690 |
| 69 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.24311844 |
| 70 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.23677349 |
| 71 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.23175989 |
| 72 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.21585051 |
| 73 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.20494952 |
| 74 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.18808631 |
| 75 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.16233541 |
| 76 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.15804756 |
| 77 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.15440193 |
| 78 | GATA1_19941826_ChIP-Seq_K562_Human | 1.14360686 |
| 79 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.13916688 |
| 80 | SOX2_18358816_ChIP-ChIP_MESCs_Mouse | 1.12174052 |
| 81 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.12131558 |
| 82 | KLF5_25053715_ChIP-Seq_YYC3_Human | 1.12129768 |
| 83 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 1.11369567 |
| 84 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 1.08568234 |
| 85 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.05765310 |
| 86 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.05035423 |
| 87 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.03384144 |
| 88 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.02745471 |
| 89 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.02519503 |
| 90 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.02286880 |
| 91 | SPI1_23127762_ChIP-Seq_K562_Human | 1.01644161 |
| 92 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.01233556 |
| 93 | GATA6_25053715_ChIP-Seq_YYC3_Human | 1.00384466 |
| 94 | ISL1_27105846_Chip-Seq_CPCs_Mouse | 1.00217334 |
| 95 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.97992571 |
| 96 | KDM2B_26808549_Chip-Seq_K562_Human | 0.97305300 |
| 97 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.96925185 |
| 98 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.96869435 |
| 99 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.96869435 |
| 100 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 0.96778582 |
| 101 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.96626466 |
| 102 | TP63_23658742_ChIP-Seq_EP156T_Human | 0.94460208 |
| 103 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.91622698 |
| 104 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 0.91217176 |
| 105 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.89955359 |
| 106 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.89741970 |
| 107 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 0.88837000 |
| 108 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.88650269 |
| 109 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 0.88631020 |
| 110 | BRD4_25478319_ChIP-Seq_HGPS_Human | 0.88397506 |
| 111 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.88340332 |
| 112 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 0.87647616 |
| 113 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 0.86729399 |
| 114 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.86203393 |
| 115 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 0.86061579 |
| 116 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.85992357 |
| 117 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 0.85935158 |
| 118 | GATA2_19941826_ChIP-Seq_K562_Human | 0.85891195 |
| 119 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.84879169 |
| 120 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.84359672 |
| 121 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.84097153 |
| 122 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 0.84086216 |
| 123 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 0.83969388 |
| 124 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.83841891 |
| 125 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.81012968 |
| 126 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.79201016 |
| 127 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.78593211 |
| 128 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 0.77225316 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * MP0001958_emphysema | 4.42780368 |
| 2 | MP0010368_abnormal_lymphatic_system | 4.09534824 |
| 3 | MP0002138_abnormal_hepatobiliary_system | 3.87751547 |
| 4 | MP0005083_abnormal_biliary_tract | 3.68502701 |
| 5 | MP0008004_abnormal_stomach_pH | 3.59673697 |
| 6 | MP0001177_atelectasis | 3.10800360 |
| 7 | MP0001879_abnormal_lymphatic_vessel | 3.08729853 |
| 8 | MP0005167_abnormal_blood-brain_barrier | 2.80178471 |
| 9 | MP0003724_increased_susceptibility_to | 2.74670391 |
| 10 | * MP0002133_abnormal_respiratory_system | 2.69704609 |
| 11 | * MP0005388_respiratory_system_phenotype | 2.69704609 |
| 12 | MP0002295_abnormal_pulmonary_circulatio | 2.61807196 |
| 13 | MP0004272_abnormal_basement_membrane | 2.53767253 |
| 14 | MP0000537_abnormal_urethra_morphology | 2.40949958 |
| 15 | MP0003191_abnormal_cellular_cholesterol | 2.35551583 |
| 16 | MP0002132_abnormal_respiratory_system | 2.11651486 |
| 17 | MP0000566_synostosis | 2.01003677 |
| 18 | MP0004782_abnormal_surfactant_physiolog | 10.1442224 |
| 19 | MP0010234_abnormal_vibrissa_follicle | 1.91613731 |
| 20 | MP0009780_abnormal_chondrocyte_physiolo | 1.77956909 |
| 21 | * MP0008995_early_reproductive_senescence | 1.69585642 |
| 22 | MP0003566_abnormal_cell_adhesion | 1.59953769 |
| 23 | MP0008875_abnormal_xenobiotic_pharmacok | 1.56301066 |
| 24 | MP0003115_abnormal_respiratory_system | 1.52091632 |
| 25 | * MP0001175_abnormal_lung_morphology | 1.51901893 |
| 26 | MP0005058_abnormal_lysosome_morphology | 1.50022888 |
| 27 | MP0003690_abnormal_glial_cell | 1.50012952 |
| 28 | MP0005275_abnormal_skin_tensile | 1.46118598 |
| 29 | MP0002277_abnormal_respiratory_mucosa | 1.44528616 |
| 30 | MP0005408_hypopigmentation | 1.34861831 |
| 31 | MP0000343_altered_response_to | 1.33582384 |
| 32 | MP0002998_abnormal_bone_remodeling | 1.33013772 |
| 33 | MP0003950_abnormal_plasma_membrane | 1.32208589 |
| 34 | MP0004883_abnormal_blood_vessel | 1.29822261 |
| 35 | MP0000534_abnormal_ureter_morphology | 1.23550620 |
| 36 | MP0005164_abnormal_response_to | 1.23240058 |
| 37 | MP0003941_abnormal_skin_development | 1.21202251 |
| 38 | MP0000767_abnormal_smooth_muscle | 1.21143197 |
| 39 | MP0003705_abnormal_hypodermis_morpholog | 1.19695088 |
| 40 | MP0010678_abnormal_skin_adnexa | 1.18065156 |
| 41 | MP0006054_spinal_hemorrhage | 1.15814936 |
| 42 | MP0008438_abnormal_cutaneous_collagen | 1.13160627 |
| 43 | MP0003279_aneurysm | 1.11218382 |
| 44 | MP0000249_abnormal_blood_vessel | 1.10194381 |
| 45 | MP0005503_abnormal_tendon_morphology | 1.09237021 |
| 46 | MP0002098_abnormal_vibrissa_morphology | 1.06664494 |
| 47 | MP0005023_abnormal_wound_healing | 1.06091672 |
| 48 | MP0001986_abnormal_taste_sensitivity | 1.04784457 |
| 49 | MP0000465_gastrointestinal_hemorrhage | 1.03878313 |
| 50 | MP0005595_abnormal_vascular_smooth | 1.02682999 |
| 51 | MP0010352_gastrointestinal_tract_polyps | 0.99328386 |
| 52 | MP0005397_hematopoietic_system_phenotyp | 0.99125225 |
| 53 | MP0001545_abnormal_hematopoietic_system | 0.99125225 |
| 54 | MP0003091_abnormal_cell_migration | 0.98224826 |
| 55 | MP0006138_congestive_heart_failure | 0.97409272 |
| 56 | MP0002796_impaired_skin_barrier | 0.96581696 |
| 57 | MP0001756_abnormal_urination | 0.94106949 |
| 58 | MP0000383_abnormal_hair_follicle | 0.93131915 |
| 59 | MP0002405_respiratory_system_inflammati | 0.92186407 |
| 60 | MP0002332_abnormal_exercise_endurance | 0.90867671 |
| 61 | MP0005367_renal/urinary_system_phenotyp | 0.89263556 |
| 62 | MP0000516_abnormal_urinary_system | 0.89263556 |
| 63 | MP0003303_peritoneal_inflammation | 0.89221841 |
| 64 | MP0005025_abnormal_response_to | 0.88565592 |
| 65 | MP0002419_abnormal_innate_immunity | 0.85745843 |
| 66 | MP0000462_abnormal_digestive_system | 0.84593291 |
| 67 | MP0002139_abnormal_hepatobiliary_system | 0.84251261 |
| 68 | MP0005166_decreased_susceptibility_to | 0.82450250 |
| 69 | MP0003436_decreased_susceptibility_to | 0.81696895 |
| 70 | MP0002166_altered_tumor_susceptibility | 0.81665814 |
| 71 | MP0002925_abnormal_cardiovascular_devel | 0.80013467 |
| 72 | MP0002282_abnormal_trachea_morphology | 0.79904292 |
| 73 | MP0002909_abnormal_adrenal_gland | 0.79346171 |
| 74 | MP0002128_abnormal_blood_circulation | 0.78870973 |
| 75 | MP0005085_abnormal_gallbladder_physiolo | 0.77352778 |
| 76 | MP0003453_abnormal_keratinocyte_physiol | 0.77260016 |
| 77 | MP0001501_abnormal_sleep_pattern | 0.76622265 |
| 78 | MP0006082_CNS_inflammation | 0.75888537 |
| 79 | MP0009384_cardiac_valve_regurgitation | 0.73942520 |
| 80 | MP0001661_extended_life_span | 0.73755632 |
| 81 | MP0001533_abnormal_skeleton_physiology | 0.72912022 |
| 82 | MP0001614_abnormal_blood_vessel | 0.71305947 |
| 83 | MP0000013_abnormal_adipose_tissue | 0.70731755 |
| 84 | * MP0001943_abnormal_respiration | 0.70638269 |
| 85 | MP0005076_abnormal_cell_differentiation | 0.69426240 |
| 86 | MP0003828_pulmonary_edema | 0.69225794 |
| 87 | MP0003448_altered_tumor_morphology | 0.68742205 |
| 88 | MP0003119_abnormal_digestive_system | 0.66821313 |
| 89 | MP0003656_abnormal_erythrocyte_physiolo | 0.66342850 |
| 90 | MP0001666_abnormal_nutrient_absorption | 0.65668592 |
| 91 | MP0002733_abnormal_thermal_nociception | 0.65475576 |
| 92 | MP0005647_abnormal_sex_gland | 0.64931422 |
| 93 | MP0002118_abnormal_lipid_homeostasis | 0.64186762 |
| 94 | MP0002168_other_aberrant_phenotype | 0.64154510 |
| 95 | MP0005332_abnormal_amino_acid | 0.63951417 |
| 96 | MP0003890_abnormal_embryonic-extraembry | 0.63592008 |
| 97 | MP0003075_altered_response_to | 0.63074333 |
| 98 | MP0003300_gastrointestinal_ulcer | 0.63004671 |
| 99 | MP0001544_abnormal_cardiovascular_syste | 0.62844105 |
| 100 | MP0005385_cardiovascular_system_phenoty | 0.62844105 |
| 101 | MP0003638_abnormal_response/metabolism_ | 0.62496339 |
| 102 | MP0002234_abnormal_pharynx_morphology | 0.62339811 |
| 103 | MP0004185_abnormal_adipocyte_glucose | 0.62211561 |
| 104 | MP0000681_abnormal_thyroid_gland | 0.60487773 |
| 105 | MP0010329_abnormal_lipoprotein_level | 0.60388515 |
| 106 | MP0002136_abnormal_kidney_physiology | 0.60146573 |
| 107 | MP0000627_abnormal_mammary_gland | 0.59833591 |
| 108 | MP0001664_abnormal_digestion | 0.59251413 |
| 109 | MP0005387_immune_system_phenotype | 0.59039050 |
| 110 | MP0001790_abnormal_immune_system | 0.59039050 |
| 111 | MP0002009_preneoplasia | 0.58330663 |
| 112 | MP0001849_ear_inflammation | 0.58040204 |
| 113 | MP0004947_skin_inflammation | 0.57949692 |
| 114 | MP0005248_abnormal_Harderian_gland | 0.57124786 |
| 115 | MP0009643_abnormal_urine_homeostasis | 0.55795507 |
| 116 | MP0004085_abnormal_heartbeat | 0.55654932 |
| 117 | MP0000470_abnormal_stomach_morphology | 0.54405420 |
| 118 | MP0003943_abnormal_hepatobiliary_system | 0.53834997 |
| 119 | MP0005165_increased_susceptibility_to | 0.53719863 |
| 120 | MP0001346_abnormal_lacrimal_gland | 0.53541530 |
| 121 | MP0002135_abnormal_kidney_morphology | 0.53384155 |
| 122 | MP0001542_abnormal_bone_strength | 0.53218536 |
| 123 | MP0002877_abnormal_melanocyte_morpholog | 0.52853832 |
| 124 | MP0010030_abnormal_orbit_morphology | 0.52612743 |
| 125 | MP0001853_heart_inflammation | 0.52392273 |
| 126 | MP0002933_joint_inflammation | 0.51762445 |
| 127 | * MP0001851_eye_inflammation | 0.51273174 |
| 128 | MP0009840_abnormal_foam_cell | 0.50896188 |
| 129 | MP0004084_abnormal_cardiac_muscle | 0.50412103 |
| 130 | MP0008961_abnormal_basal_metabolism | 0.50377571 |
| 131 | MP0008775_abnormal_heart_ventricle | 0.49464141 |
| 132 | MP0009764_decreased_sensitivity_to | 0.49312946 |
| 133 | MP0004484_altered_response_of | 0.49196395 |
| 134 | MP0000604_amyloidosis | 0.47558612 |
| 135 | MP0003045_fibrosis | 0.47383282 |
| 136 | MP0008469_abnormal_protein_level | 0.47146632 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * Interstitial pulmonary disease (HP:0006530) | 9.80241202 |
| 2 | Hyperactive renin-angiotensin system (HP:0000841) | 6.79761684 |
| 3 | Chronic bronchitis (HP:0004469) | 6.23615448 |
| 4 | Abnormality of the fingertips (HP:0001211) | 6.14737714 |
| 5 | Systemic lupus erythematosus (HP:0002725) | 5.80515804 |
| 6 | Renal salt wasting (HP:0000127) | 5.41651280 |
| 7 | Polycythemia (HP:0001901) | 5.33680540 |
| 8 | Glomerulonephritis (HP:0000099) | 5.23242267 |
| 9 | Complement deficiency (HP:0004431) | 5.21277072 |
| 10 | Alveolar cell carcinoma (HP:0006519) | 5.12347329 |
| 11 | Onycholysis (HP:0001806) | 5.01542478 |
| 12 | Hematochezia (HP:0002573) | 4.99998044 |
| 13 | Neoplasm of the tracheobronchial system (HP:0100552) | 4.74939183 |
| 14 | Spontaneous hematomas (HP:0007420) | 4.42122279 |
| 15 | Abnormality of complement system (HP:0005339) | 4.37242321 |
| 16 | Abnormality of the nasal mucosa (HP:0000433) | 4.31671933 |
| 17 | Gout (HP:0001997) | 4.29295181 |
| 18 | Exertional dyspnea (HP:0002875) | 4.16147812 |
| 19 | Hyperkalemia (HP:0002153) | 4.12592719 |
| 20 | * Respiratory distress (HP:0002098) | 4.02918384 |
| 21 | Neurofibrillary tangles (HP:0002185) | 4.00590771 |
| 22 | Visceral angiomatosis (HP:0100761) | 3.76115564 |
| 23 | Abnormal umbilical cord blood vessels (HP:0011403) | 3.75156029 |
| 24 | Single umbilical artery (HP:0001195) | 3.75156029 |
| 25 | Abnormality of the fetal cardiovascular system (HP:0010948) | 3.75156029 |
| 26 | * Tachypnea (HP:0002789) | 3.65555834 |
| 27 | Long toe (HP:0010511) | 3.60466540 |
| 28 | Hemangiomatosis (HP:0007461) | 3.53766826 |
| 29 | Tubulointerstitial nephritis (HP:0001970) | 3.52265384 |
| 30 | Ulnar bowing (HP:0003031) | 3.45114217 |
| 31 | Pulmonary fibrosis (HP:0002206) | 3.37657849 |
| 32 | Esophageal varix (HP:0002040) | 3.26739338 |
| 33 | Segmental peripheral demyelination/remyelination (HP:0003481) | 3.18838943 |
| 34 | Bronchitis (HP:0012387) | 3.17993504 |
| 35 | Cerebral inclusion bodies (HP:0100314) | 3.12901991 |
| 36 | Chronic otitis media (HP:0000389) | 3.11787355 |
| 37 | Broad metatarsal (HP:0001783) | 3.09884858 |
| 38 | Hyperaldosteronism (HP:0000859) | 3.08976897 |
| 39 | Cerebral aneurysm (HP:0004944) | 3.06277997 |
| 40 | Hypotension (HP:0002615) | 3.03327593 |
| 41 | Hypergammaglobulinemia (HP:0010702) | 2.99689350 |
| 42 | Ulnar claw (HP:0001178) | 2.97447412 |
| 43 | Abnormality of chloride homeostasis (HP:0011422) | 2.86147233 |
| 44 | * Tubulointerstitial fibrosis (HP:0005576) | 2.81784439 |
| 45 | Neoplasm of the lung (HP:0100526) | 2.81531912 |
| 46 | Fragile nails (HP:0001808) | 2.75353932 |
| 47 | Conjunctival telangiectasia (HP:0000524) | 2.69321788 |
| 48 | Abnormality of renin-angiotensin system (HP:0000847) | 2.68697936 |
| 49 | Pulmonary hypertension (HP:0002092) | 2.68384088 |
| 50 | Cerebral hemorrhage (HP:0001342) | 2.68095538 |
| 51 | Glucose intolerance (HP:0000833) | 2.67164818 |
| 52 | Decreased circulating renin level (HP:0003351) | 2.62777406 |
| 53 | Bronchomalacia (HP:0002780) | 2.58616236 |
| 54 | Osteolytic defects of the hand bones (HP:0009699) | 2.58356928 |
| 55 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.58356928 |
| 56 | Milia (HP:0001056) | 2.53522413 |
| 57 | Atrophic scars (HP:0001075) | 2.52590793 |
| 58 | Growth hormone excess (HP:0000845) | 2.52262347 |
| 59 | Stomach cancer (HP:0012126) | 2.52061405 |
| 60 | Tubular atrophy (HP:0000092) | 2.50189450 |
| 61 | Neonatal respiratory distress (HP:0002643) | 2.49741727 |
| 62 | Hyperpituitarism (HP:0010514) | 2.48206581 |
| 63 | Subcapsular cataract (HP:0000523) | 2.46088596 |
| 64 | Neoplasm of the respiratory system (HP:0100606) | 2.42021874 |
| 65 | Supranuclear gaze palsy (HP:0000605) | 2.40955226 |
| 66 | Thyroid-stimulating hormone excess (HP:0002925) | 2.40241605 |
| 67 | Bowed forearm bones (HP:0003956) | 2.38359485 |
| 68 | Bowing of the arm (HP:0006488) | 2.38359485 |
| 69 | Loss of speech (HP:0002371) | 2.37272517 |
| 70 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 2.37070885 |
| 71 | Potter facies (HP:0002009) | 2.36741068 |
| 72 | Facial shape deformation (HP:0011334) | 2.36741068 |
| 73 | Posterior subcapsular cataract (HP:0007787) | 2.36266600 |
| 74 | Increased CSF protein (HP:0002922) | 2.35928134 |
| 75 | Deep venous thrombosis (HP:0002625) | 2.32925132 |
| 76 | Distal lower limb muscle weakness (HP:0009053) | 2.32854328 |
| 77 | Midline defect of the nose (HP:0004122) | 2.31704174 |
| 78 | Restrictive lung disease (HP:0002091) | 2.30662539 |
| 79 | Shawl scrotum (HP:0000049) | 2.26282394 |
| 80 | Stenosis of the external auditory canal (HP:0000402) | 2.23648952 |
| 81 | Subacute progressive viral hepatitis (HP:0006572) | 2.22154616 |
| 82 | Arterial tortuosity (HP:0005116) | 2.19550886 |
| 83 | Microcytic anemia (HP:0001935) | 2.19241396 |
| 84 | Recurrent abscess formation (HP:0002722) | 2.16559992 |
| 85 | Cavernous hemangioma (HP:0001048) | 2.16097793 |
| 86 | Hyponatremia (HP:0002902) | 2.15401044 |
| 87 | Shallow orbits (HP:0000586) | 2.15266857 |
| 88 | Vascular tortuosity (HP:0004948) | 2.13842387 |
| 89 | Glomerulosclerosis (HP:0000096) | 2.12975430 |
| 90 | Intestinal atresia (HP:0011100) | 2.12181800 |
| 91 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.11772133 |
| 92 | Striae distensae (HP:0001065) | 2.10068223 |
| 93 | Pulmonary artery stenosis (HP:0004415) | 2.09048483 |
| 94 | Hypokalemic alkalosis (HP:0001949) | 2.07850662 |
| 95 | Flexion contracture of toe (HP:0005830) | 2.07528407 |
| 96 | Joint contractures involving the joints of the feet (HP:0100492) | 2.07528407 |
| 97 | Abnormality of the umbilical cord (HP:0010881) | 2.04643573 |
| 98 | Camptodactyly of toe (HP:0001836) | 2.02304814 |
| 99 | Seborrheic dermatitis (HP:0001051) | 1.96722192 |
| 100 | Bronchiectasis (HP:0002110) | 1.96424384 |
| 101 | Megalencephaly (HP:0001355) | 1.96356613 |
| 102 | Annular pancreas (HP:0001734) | 1.95526994 |
| 103 | Joint swelling (HP:0001386) | 1.93670168 |
| 104 | Increased purine levels (HP:0004368) | 1.92498440 |
| 105 | Hyperuricemia (HP:0002149) | 1.92498440 |
| 106 | Rectal prolapse (HP:0002035) | 1.91296094 |
| 107 | Abnormality of macrophages (HP:0004311) | 1.89690336 |
| 108 | Progressive sensorineural hearing impairment (HP:0000408) | 1.89490655 |
| 109 | Plantar hyperkeratosis (HP:0007556) | 1.89237972 |
| 110 | Aplasia involving bones of the upper limbs (HP:0009823) | 1.87611023 |
| 111 | Aplasia of the phalanges of the hand (HP:0009802) | 1.87611023 |
| 112 | Aplasia involving bones of the extremities (HP:0009825) | 1.87611023 |
| 113 | Mucosal telangiectasiae (HP:0100579) | 1.84657334 |
| 114 | Polar cataract (HP:0010696) | 1.84520303 |
| 115 | Synostosis involving the elbow (HP:0003938) | 1.83831518 |
| 116 | Humeroradial synostosis (HP:0003041) | 1.83831518 |
| 117 | Aortic aneurysm (HP:0004942) | 1.82734299 |
| 118 | Abnormal glucose tolerance (HP:0001952) | 1.81785111 |
| 119 | Eczematoid dermatitis (HP:0000976) | 1.81126965 |
| 120 | Rapidly progressive (HP:0003678) | 1.80716055 |
| 121 | Nephritis (HP:0000123) | 1.78953760 |
| 122 | Abnormality of the gastric mucosa (HP:0004295) | 1.76608305 |
| 123 | Purpura (HP:0000979) | 1.75593878 |
| 124 | Broad distal phalanx of finger (HP:0009836) | 1.74759093 |
| 125 | Skin nodule (HP:0200036) | 1.74589765 |
| 126 | Myocardial infarction (HP:0001658) | 1.74494996 |
| 127 | Reduced subcutaneous adipose tissue (HP:0003758) | 1.73127447 |
| 128 | Wormian bones (HP:0002645) | 1.73046638 |
| 129 | Abnormality of the pulmonary veins (HP:0011718) | 1.72703301 |
| 130 | Absent eyebrow (HP:0002223) | 1.72440455 |
| 131 | Flat capital femoral epiphysis (HP:0003370) | 1.72191585 |
| 132 | Right ventricular cardiomyopathy (HP:0011663) | 1.70902593 |
| 133 | Prostate neoplasm (HP:0100787) | 1.69607164 |
| 134 | Onion bulb formation (HP:0003383) | 1.67056810 |
| 135 | Increased connective tissue (HP:0009025) | 1.65771909 |
| 136 | Difficulty walking (HP:0002355) | 1.62902708 |
| 137 | Adrenal overactivity (HP:0002717) | 1.59005633 |
| 138 | Mucopolysacchariduria (HP:0008155) | 1.58883186 |
| 139 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.58883186 |
| 140 | Absent hand (HP:0004050) | 1.56442772 |
| 141 | Cerebral palsy (HP:0100021) | 1.56228202 |
| 142 | Aneurysm (HP:0002617) | 1.55778874 |
| 143 | Adactyly (HP:0009776) | 1.54533127 |
| 144 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.48138762 |
| 145 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.48138762 |
| 146 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.48138762 |
| 147 | Mitral valve prolapse (HP:0001634) | 1.47969425 |
| 148 | Bone cyst (HP:0012062) | 1.46799280 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TIE1 | 6.09455356 |
| 2 | TGFBR2 | 4.25944333 |
| 3 | FGFR2 | 4.16231813 |
| 4 | STK24 | 3.78868893 |
| 5 | LRRK2 | 3.29438900 |
| 6 | PAK4 | 2.74157080 |
| 7 | EPHB2 | 2.57081859 |
| 8 | MST4 | 2.33584225 |
| 9 | ZAP70 | 2.23809157 |
| 10 | DAPK2 | 2.22537592 |
| 11 | RIPK1 | 2.13617361 |
| 12 | LMTK2 | 2.12588401 |
| 13 | EPHB1 | 2.06971064 |
| 14 | GRK1 | 2.04388368 |
| 15 | TRIB3 | 1.98639396 |
| 16 | ILK | 1.98546252 |
| 17 | EPHA2 | 1.91684195 |
| 18 | MAP3K3 | 1.90795578 |
| 19 | STK10 | 1.87976216 |
| 20 | MAP3K6 | 1.83796448 |
| 21 | FER | 1.79140988 |
| 22 | PDGFRB | 1.70749181 |
| 23 | TESK1 | 1.69841127 |
| 24 | CDC42BPA | 1.65315830 |
| 25 | NLK | 1.62536973 |
| 26 | MAP3K2 | 1.61812336 |
| 27 | MYLK | 1.59746589 |
| 28 | RPS6KA2 | 1.58241457 |
| 29 | FGFR4 | 1.53943087 |
| 30 | PRPF4B | 1.53679343 |
| 31 | PTK6 | 1.50538742 |
| 32 | MARK2 | 1.48752897 |
| 33 | TGFBR1 | 1.40845899 |
| 34 | STK38L | 1.35674828 |
| 35 | AKT3 | 1.29680300 |
| 36 | ERN1 | 1.28906666 |
| 37 | MST1R | 1.28664911 |
| 38 | MAP3K12 | 1.26987872 |
| 39 | LATS2 | 1.25052965 |
| 40 | MAP3K14 | 1.23029040 |
| 41 | LATS1 | 1.20667836 |
| 42 | MAPK7 | 1.13788049 |
| 43 | CSK | 1.11118387 |
| 44 | MAPK12 | 1.09636363 |
| 45 | KDR | 1.08702997 |
| 46 | PDGFRA | 1.07800229 |
| 47 | MAPK15 | 1.07276684 |
| 48 | MET | 1.06437283 |
| 49 | BCR | 1.06059886 |
| 50 | YES1 | 1.04544343 |
| 51 | IRAK1 | 1.04114235 |
| 52 | LIMK1 | 1.02999889 |
| 53 | HIPK2 | 0.96024671 |
| 54 | NTRK3 | 0.89826309 |
| 55 | BLK | 0.87567747 |
| 56 | GSK3A | 0.87471502 |
| 57 | CDK6 | 0.87007072 |
| 58 | FRK | 0.86856379 |
| 59 | FGFR3 | 0.85960578 |
| 60 | NEK9 | 0.82944814 |
| 61 | EPHA3 | 0.81643791 |
| 62 | SGK2 | 0.80872805 |
| 63 | CAMK1D | 0.80482120 |
| 64 | PTK2 | 0.78748778 |
| 65 | EGFR | 0.72195254 |
| 66 | PTK2B | 0.69642241 |
| 67 | RET | 0.66545779 |
| 68 | PRKD1 | 0.65519933 |
| 69 | TTN | 0.64873008 |
| 70 | MAP2K3 | 0.63501345 |
| 71 | KIT | 0.63311323 |
| 72 | PDK2 | 0.62873430 |
| 73 | PRKCQ | 0.60934965 |
| 74 | SGK223 | 0.60651398 |
| 75 | SGK494 | 0.60651398 |
| 76 | ERBB3 | 0.60178739 |
| 77 | KSR2 | 0.60107437 |
| 78 | TAOK3 | 0.59804673 |
| 79 | DAPK1 | 0.58179935 |
| 80 | RPS6KA4 | 0.56154324 |
| 81 | GRK5 | 0.56148738 |
| 82 | DDR2 | 0.55118257 |
| 83 | JAK2 | 0.54588071 |
| 84 | STK38 | 0.54386377 |
| 85 | TYK2 | 0.53770727 |
| 86 | MAPKAPK3 | 0.53353666 |
| 87 | MATK | 0.51950707 |
| 88 | MAP3K9 | 0.51776247 |
| 89 | INSR | 0.50698684 |
| 90 | MAPKAPK2 | 0.49127532 |
| 91 | CHUK | 0.48409152 |
| 92 | DAPK3 | 0.47983800 |
| 93 | NME1 | 0.46442436 |
| 94 | ERBB2 | 0.46339342 |
| 95 | MAP2K2 | 0.46251433 |
| 96 | MOS | 0.44508174 |
| 97 | MAPK4 | 0.44418288 |
| 98 | PRKG2 | 0.44333846 |
| 99 | GRK7 | 0.44301212 |
| 100 | NEK6 | 0.44291756 |
| 101 | MAP2K1 | 0.44079091 |
| 102 | PDK1 | 0.43501129 |
| 103 | SIK1 | 0.43450847 |
| 104 | ROCK1 | 0.43170084 |
| 105 | PRKCH | 0.43032099 |
| 106 | MAPK3 | 0.42839078 |
| 107 | MAP3K13 | 0.42195710 |
| 108 | PDPK1 | 0.40663223 |
| 109 | JAK1 | 0.40453752 |
| 110 | MAP3K1 | 0.40267302 |
| 111 | ROCK2 | 0.39812747 |
| 112 | FGFR1 | 0.38536447 |
| 113 | MTOR | 0.38502486 |
| 114 | NTRK1 | 0.38244677 |
| 115 | DMPK | 0.37813429 |
| 116 | SGK3 | 0.37593913 |
| 117 | TEC | 0.35218647 |
| 118 | EEF2K | 0.35049930 |
| 119 | BRSK2 | 0.35013372 |
| 120 | RPS6KA1 | 0.34527122 |
| 121 | MAP3K7 | 0.33782212 |
| 122 | TBK1 | 0.32489062 |
| 123 | PKN2 | 0.31992222 |
| 124 | TRPM7 | 0.30392910 |
| 125 | WNK4 | 0.30128330 |
| 126 | RPS6KL1 | 0.28574493 |
| 127 | RPS6KC1 | 0.28574493 |
| 128 | FGR | 0.28219475 |
| 129 | MARK3 | 0.27469329 |
| 130 | PRKCE | 0.27260728 |
| 131 | IGF1R | 0.27082564 |
| 132 | ABL1 | 0.26221854 |
| 133 | RPS6KA6 | 0.26107409 |
| 134 | IKBKE | 0.25862674 |
| 135 | SRC | 0.23990519 |
| 136 | FYN | 0.23691533 |
| 137 | PRKCD | 0.23504838 |
| 138 | STK39 | 0.22310024 |
| 139 | CAMK1G | 0.21295797 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 3.09253269 |
| 2 | Mineral absorption_Homo sapiens_hsa04978 | 2.91965902 |
| 3 | ECM-receptor interaction_Homo sapiens_hsa04512 | 2.88196871 |
| 4 | Caffeine metabolism_Homo sapiens_hsa00232 | 2.67679566 |
| 5 | Adherens junction_Homo sapiens_hsa04520 | 2.65156226 |
| 6 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 2.52263445 |
| 7 | Tight junction_Homo sapiens_hsa04530 | 2.39803414 |
| 8 | Asthma_Homo sapiens_hsa05310 | 2.16015588 |
| 9 | Lysosome_Homo sapiens_hsa04142 | 2.04724880 |
| 10 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 2.03473109 |
| 11 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.99562644 |
| 12 | Phagosome_Homo sapiens_hsa04145 | 1.97089900 |
| 13 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.89695100 |
| 14 | Focal adhesion_Homo sapiens_hsa04510 | 1.86841600 |
| 15 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.86572155 |
| 16 | Allograft rejection_Homo sapiens_hsa05330 | 1.79420625 |
| 17 | Pertussis_Homo sapiens_hsa05133 | 1.79374970 |
| 18 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.78481018 |
| 19 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.69816387 |
| 20 | Hippo signaling pathway_Homo sapiens_hsa04390 | 1.68478887 |
| 21 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.68384880 |
| 22 | Bladder cancer_Homo sapiens_hsa05219 | 1.66913842 |
| 23 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.60449515 |
| 24 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.56976601 |
| 25 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.50228223 |
| 26 | Amoebiasis_Homo sapiens_hsa05146 | 1.49783703 |
| 27 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.49093325 |
| 28 | Renin-angiotensin system_Homo sapiens_hsa04614 | 1.48908130 |
| 29 | Malaria_Homo sapiens_hsa05144 | 1.43929825 |
| 30 | Leishmaniasis_Homo sapiens_hsa05140 | 1.38133192 |
| 31 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.37998577 |
| 32 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 1.35167337 |
| 33 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.32266324 |
| 34 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.30492920 |
| 35 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.26770995 |
| 36 | Other glycan degradation_Homo sapiens_hsa00511 | 1.26699962 |
| 37 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.26542815 |
| 38 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 1.25072624 |
| 39 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.24523109 |
| 40 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 1.23664923 |
| 41 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.22461114 |
| 42 | Platelet activation_Homo sapiens_hsa04611 | 1.20215373 |
| 43 | Thyroid cancer_Homo sapiens_hsa05216 | 1.19884197 |
| 44 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.18200975 |
| 45 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 1.15996783 |
| 46 | Renal cell carcinoma_Homo sapiens_hsa05211 | 1.14883619 |
| 47 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.13211527 |
| 48 | Axon guidance_Homo sapiens_hsa04360 | 1.09476040 |
| 49 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.08576272 |
| 50 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.07853161 |
| 51 | Hepatitis C_Homo sapiens_hsa05160 | 1.04554006 |
| 52 | Histidine metabolism_Homo sapiens_hsa00340 | 1.02936940 |
| 53 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.02269982 |
| 54 | Endocytosis_Homo sapiens_hsa04144 | 0.99241476 |
| 55 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.98494028 |
| 56 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.98284480 |
| 57 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.97230041 |
| 58 | Circadian rhythm_Homo sapiens_hsa04710 | 0.93032544 |
| 59 | Renin secretion_Homo sapiens_hsa04924 | 0.92214148 |
| 60 | Viral myocarditis_Homo sapiens_hsa05416 | 0.91301411 |
| 61 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.90687704 |
| 62 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.90062528 |
| 63 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.88572547 |
| 64 | Pathways in cancer_Homo sapiens_hsa05200 | 0.88070230 |
| 65 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.85779855 |
| 66 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.85558060 |
| 67 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.83286949 |
| 68 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.83171226 |
| 69 | Taste transduction_Homo sapiens_hsa04742 | 0.82870508 |
| 70 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.81777994 |
| 71 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.81298454 |
| 72 | Salmonella infection_Homo sapiens_hsa05132 | 0.80997944 |
| 73 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.80730884 |
| 74 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.80216456 |
| 75 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.78140952 |
| 76 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.76948772 |
| 77 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.76926711 |
| 78 | Endometrial cancer_Homo sapiens_hsa05213 | 0.76699053 |
| 79 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.76266282 |
| 80 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.74988394 |
| 81 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.72919422 |
| 82 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.72821127 |
| 83 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.70690176 |
| 84 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.70042795 |
| 85 | Influenza A_Homo sapiens_hsa05164 | 0.68732242 |
| 86 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.68684573 |
| 87 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.67259580 |
| 88 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.65812640 |
| 89 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.64768570 |
| 90 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.64384485 |
| 91 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.63115785 |
| 92 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.62689688 |
| 93 | Apoptosis_Homo sapiens_hsa04210 | 0.62327266 |
| 94 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.61536407 |
| 95 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.61077195 |
| 96 | Shigellosis_Homo sapiens_hsa05131 | 0.59687418 |
| 97 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.59562759 |
| 98 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.59510994 |
| 99 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.58941189 |
| 100 | ABC transporters_Homo sapiens_hsa02010 | 0.57380794 |
| 101 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.55735267 |
| 102 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.54834655 |
| 103 | Bile secretion_Homo sapiens_hsa04976 | 0.54634885 |
| 104 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.54588015 |
| 105 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.54524278 |
| 106 | Salivary secretion_Homo sapiens_hsa04970 | 0.53359396 |
| 107 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.52736898 |
| 108 | Melanogenesis_Homo sapiens_hsa04916 | 0.52547912 |
| 109 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.52375238 |
| 110 | Prion diseases_Homo sapiens_hsa05020 | 0.51853651 |
| 111 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.51302869 |
| 112 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.50324588 |
| 113 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.49043824 |
| 114 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.48932694 |
| 115 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.48886232 |
| 116 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.47945491 |
| 117 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.47510171 |
| 118 | Colorectal cancer_Homo sapiens_hsa05210 | 0.46931373 |
| 119 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.46669704 |
| 120 | Prostate cancer_Homo sapiens_hsa05215 | 0.46102062 |
| 121 | Long-term depression_Homo sapiens_hsa04730 | 0.45936246 |
| 122 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.45933174 |
| 123 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.45135691 |
| 124 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.44406243 |
| 125 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.42562918 |
| 126 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.42329587 |
| 127 | Gap junction_Homo sapiens_hsa04540 | 0.42037079 |
| 128 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.41849911 |
| 129 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.41245742 |
| 130 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.40746405 |
| 131 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.40189413 |
| 132 | Peroxisome_Homo sapiens_hsa04146 | 0.40162670 |
| 133 | Melanoma_Homo sapiens_hsa05218 | 0.39635391 |
| 134 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.39626844 |
| 135 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.38069125 |
| 136 | Insulin resistance_Homo sapiens_hsa04931 | 0.37620227 |
| 137 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.37334679 |
| 138 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.37039156 |
| 139 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.35673904 |
| 140 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.35278344 |
| 141 | Tuberculosis_Homo sapiens_hsa05152 | 0.34763585 |

